The cash influx extends Maze’s financial runway into 2025, giving the South San Francisco company time to advance other drug candidates into testing.
News Ticker
- [ May 28, 2023 ] Senior Process Engineer – (Biotech Industry) – Hybrid – Harris Group – Lafayette, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Senior Director, Head of Medical Affairs – Cargo Therapeutics – San Mateo, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Clinical Data Manager – Revolution Medicines – Redwood City, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Postdoc or Staff Computational Biologist: Quantitative Evolutionary Genomics and Ecology in Plants – Carnegie Institution – Stanford, CA San Francisco Biotech Jobs
- [ May 27, 2023 ] Research Assistant: Next Generation Sequencing and CRISPR in Plants – Carnegie Institution – Stanford, CA San Francisco Biotech Jobs
Copyright © 2023 Biotech Networks, LLC
